Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer
Clinical trial NCT04452370 · UNKNOWN
Trial details
- NCT number
- NCT04452370
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2022-07-11
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.